Diamond Pharma

Diamond Pharma Services is a specialist consultancy providing regulatory, pharmacovigilance and compliance services to the life sciences sector

[Diamond Pharma @diamondpharma]

Post-Brexit Britain may be an ideal pilot market or provide a de-risking steppingstone. Find out how we can help you navigate #Brexit​ here: https://t.co/4BGhteCDiP

[Diamond Pharma @diamondpharma]

#PharmaOpportunity - The UK should not be viewed as an afterthought but as an integral part of any regulatory strategy: we believe it offers #pharma companies a valuable early engagement and stepping stone for efficient regulatory assessment. https://t.co/4BGhteCDiP

[Diamond Pharma @diamondpharma]

Brexit upshot for #pharma companies: The MHRA should offer a rapid yet thorough analysis, and hopefully authorisation, in a pilot market of over 60 million: Find out more here: https://t.co/4BGhteCDiP

[Diamond Pharma @diamondpharma]

Early dialogue with the #MHRA may be a prudent move for pharmaceutical companies planning a UK launch: a gold standard regulator, a pragmatic risk-benefit approach and a history of contributing to novel technologies create opportunity. Find out more here: https://t.co/4BGhteCDiP

[Diamond Pharma @diamondpharma]

Diamond Pharma Services are delighted to be virtually exhibiting at Gene Therapy for Rare Disorders Europe in 2 weeks’ time! Will you be joining us? https://t.co/MkWTlQ5oTv
#GeneTherapy

[Diamond Pharma @diamondpharma]

Diamond Supports GenSight Biologics in LUMEVOQ MAA Submission https://t.co/YWZgChm3kK

[Diamond Pharma @diamondpharma]

Diamond Acquires PharmaCentral to Strengthen Pharmacovigilance Division and Enhances Senior-level Expertise

https://t.co/4Z03HJKCfZ

[Diamond Pharma @diamondpharma]

Read our consolidated COVID-19 guidance related to the regulation of medicines and associated quality and compliance matters.
https://t.co/hktZBBkYym

[Diamond Pharma @diamondpharma]

Diamond support Akcea in Waylivra MAA https://t.co/9MitjFkLY5

[Diamond Pharma @diamondpharma]

Diamond's Associate Director of Regulatory Affairs, Maria Fernandez, presented the regulatory challenges as part of the Yescarta Case Studies session at the CAR-TCR Summit Europe in London). https://t.co/gaTrfwiGBP

[Diamond Pharma @diamondpharma]

An outstanding night for @diamondpharma at the @TOPRANEWS Awards, taking home both the Support and Futures award, recognising our support for Kite's EU approval for Yescarta. #RegAwards18 #Regulatory #Excellence

[TOPRA @TOPRANEWS]

Congratulations again to @diamondpharma winner of this year's FUTURES Award! #RegAwards18 #Regulatory #Excellence

[TOPRA @TOPRANEWS]

Congratulations to @diamondpharma winner of this year's SUPPORT Award! #RegAwards18 #Regulatory #Excellence

[Diamond Pharma @diamondpharma]

UPDATED: Arie Belldegrun and David Chang score record IPO, now they plan to win the race to a historic FDA OK - https://t.co/YfZQjEiV6y

[Diamond Pharma @diamondpharma]

Diamond are extremely excited to have won the Best Specialist CRO category at #OBNAwards ⁦@OBN_UK⁩

[Diamond Pharma @diamondpharma]

Novartis drums up EU launch plans as CHMP gives thumbs up to Spark's gene therapy Luxturna - https://t.co/f9sGPw0oSq

[Diamond Pharma @diamondpharma]

After a 6-month romp, Arie Belldegrun and David Chang fly a $100M-plus IPO for off-the-shelf CAR-T player Allo ... - https://t.co/gq3B39v42h

[Diamond Pharma @diamondpharma]

Diamond are delighted to have been shortlisted for the Futures and Support categories in the 2018 TOPRA Awards #TOPRA #regulatoryaffairs https://t.co/dZKO9g3h8V

[Diamond Pharma @diamondpharma]

We are pleased to announce that Dimaond Pharma Services are finalists in the Best Specialist CRO category for the 2018 OBN Awards recognising our experience and expertise in providing regulatory affairs support to developers of cell and gene therapies. @OBN_UK #OBNAwards

[Diamond Pharma @diamondpharma]

EMA Workload Takes a Brexit Hit https://t.co/K3c8RrNT2w